Lingyi Biology
Shanghai
About Lingyi Biology
Lingyi Biology is a gene therapy company that uses a platform to validate the functionality of animal models of rare diseases. It is dedicated to sourcing innovation, with a focus on genetic rare diseases like metabolism, CNS, and ophthalmology. Lingyi Biology has a gene therapy and rare disease discovery, development, and industrialization team, as well as a rare disease animal model preparation and verification platform, to address the pain point of a lack of effective animal models for rare disease research and development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $30.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2024)
- Website: lingyimed.com
- Phone: +86 021-50581597
Industries & Categories
Biotechnology, Genetics, Medical
Canonical: https://fsome.com/organization/lingyi-biology-35130 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.